Autor:
Schousboe, M.L.
Ranjitkar, S.
Rajakaruna, R.S.
Amerasinghe, Priyanie H.
Morales, Francisco José
Pearce, R.
Ord, R.
Leslie, T.
Rowland, M.
Gadalla, N.B.
Konradsen, Flemming
Bygbjerg, C.
Roper, C.
Alifrangis, M.
Background Chloroquine combined with primaquine has been the ecommended antimalarial treatment of Plasmodium vivax malaria infections for six decades but the efficacy of this treatment regimen is threatened by chloroquine resistance (CQR). Single nucleotide polymorphisms (SNPs) in the multidrug r...
Enlace original:
https://cgspace.cgiar.org/handle/10568/69468
Schousboe, M.L.
,
Ranjitkar, S.
,
Rajakaruna, R.S.
,
Amerasinghe, Priyanie H.
,
Morales, Francisco José
,
Pearce, R.
,
Ord, R.
,
Leslie, T.
,
Rowland, M.
,
Gadalla, N.B.
,
Konradsen, Flemming
,
Bygbjerg, C.
,
Roper, C.
,
Alifrangis, M.
,
[Multiple origins of mutations in the mdr1 gene—a putative marker of chloroquine resistance in P. vivax]
,
Multiple origins of mutations in the mdr1 gene—a putative marker of chloroquine resistance in P. vivax
